Literature DB >> 20091488

Relationship of fetuin-A with glomerular filtration rate and endothelial dysfunction in moderate-severe chronic kidney disease.

Santina Cottone1, Alessandro Palermo, Rosalia Arsena, Raffella Riccobene, Marco Guarneri, Giuseppe Mulè, Francesca Tornese, Chiara Altieri, Francesco Vaccaro, Antonino Previti, Antonio Previti, Giovanni Cerasola.   

Abstract

BACKGROUND: In end-stage renal disease, fetuin-A has been demonstrated to be reduced and inversely related to cardiovascular mortality. This study had 2 distinct aims. The first was to verify if circulating concentration of fetuin-A may depend on renal function in patients with chronic kidney disease (CKD). Furthermore, we analyzed the correlation of fetuin-A with the biomarker of endothelial dysfunction endothelin-1 (ET-1), and with the inflammatory cytokine interleukin-6 (IL-6).
METHODS: In 108 subjects with stage 3-5 CKD, plasma levels of fetuin-A, ET-1 and IL-6 were assayed. Patients were studied first as a whole group and then were divided according to stages of CKD and fetuin-A tertiles.
RESULTS: Fetuin-A concentration decreased in parallel with the increase in ET-1 and IL-6 levels as renal function declined. Multiple regression analysis showed that fetuin-A was independently associated with estimated glomerular filtration rate (beta=0.386; p<0.001), IL-6 (beta=-0.393; p=0.001) and ET-1 (beta=-0.219; p=0.02), in a multivariate model including also sex, parathyroid hormone and the calcium x phosphorus product.
CONCLUSIONS: These results seem to indicate that in CKD, even when not severe, inflammatory processes are increased and linked to endothelial dysfunction, worsening progressively with the decline of renal function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20091488

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  6 in total

Review 1.  The systemic nature of CKD.

Authors:  Carmine Zoccali; Raymond Vanholder; Ziad A Massy; Alberto Ortiz; Pantelis Sarafidis; Friedo W Dekker; Danilo Fliser; Denis Fouque; Gunnar H Heine; Kitty J Jager; Mehmet Kanbay; Francesca Mallamaci; Gianfranco Parati; Patrick Rossignol; Andrzej Wiecek; Gerard London
Journal:  Nat Rev Nephrol       Date:  2017-04-24       Impact factor: 28.314

2.  Endothelin but Not Angiotensin II May Mediate Hypertension-Induced Coronary Vascular Calcification in Chronic Kidney Disease.

Authors:  Simon W Rabkin
Journal:  Int J Nephrol       Date:  2011-05-31

3.  Fetuin-A and Ghrelin Levels in Children with End Stage Renal Disease and the Effect of a Single Hemodialysis Session on Them.

Authors:  Mohamed Gamal Shouman; Nagwa Abdallah Ismail; Ahmed Badr; Safaa Mohamed Abdelrahman; Shadia Ragab; Hebatallah Farouk
Journal:  Open Access Maced J Med Sci       Date:  2015-07-17

Review 4.  Pathophysiology of Non Alcoholic Fatty Liver Disease.

Authors:  Salvatore Petta; Amalia Gastaldelli; Eleni Rebelos; Elisabetta Bugianesi; Piergiorgio Messa; Luca Miele; Gianluca Svegliati-Baroni; Luca Valenti; Ferruccio Bonino
Journal:  Int J Mol Sci       Date:  2016-12-11       Impact factor: 5.923

5.  Causal association pathways between fetuin-A and kidney function: a mediation analysis.

Authors:  Philip Etabee Bassey; Pawin Numthavaj; Sasivimol Rattanasiri; Piyamitr Sritara; Mark McEvoy; Boonsong Ongphiphadhanakul; Ammarin Thakkinstian
Journal:  J Int Med Res       Date:  2022-04       Impact factor: 1.573

Review 6.  Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease.

Authors:  Anjay Rastogi
Journal:  Ther Adv Cardiovasc Dis       Date:  2013-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.